JNJ JOHNSON & JOHNSON Earnings Reports 8-K Filing 2025 - Q3 Earnings Report Johnson & Johnson reported a significant increase in sales for the third quarter of 2023, reaching $21.3 billion, up 6.5% from the previous year, with strong performance in its pharmaceutical division.Get access to all SEC 8-K filings of the JOHNSON & JOHNSON